A federal appeals court in the US has partially backed a lower court ruling that would restrict access to the medical abortion pill mifepristone, with the dispute now like
A phase 3 trial of Merck & Co’s checkpoint inhibitor Keytruda could support the expansion of its use in cervical cancer to include newly-diagnosed patients with less s
The first-ever over-the-counter contraceptive pill has finally been approved for sale in the US, extending the choice of birth control options available to women.
Astellas has become the first drugmaker to bring a drug in the neurokinin 3 (NK3) receptor antagonist class to the US market, after getting FDA approval of fezolinetant fo
An FDA advisory committee has unanimously voted in favour of approval for what could become the first oral contraceptive to be made available in the US without a doctor’s
The US Supreme Court has said it will allow the abortion pill mifepristone to remain available while an appeal of the decision to strike down its regulatory approval make
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.